BCL2 and cancer: PUMA is a general sensor of apoptotic stimuli and a promising drug target for cancer therapy [8, 9], which induces apoptosis by activating the pro-apoptotic protein Bax through its interaction with anti-apoptotic Bcl-2 family members, including Bcl-2 and Mcl-1.